User Name:     Password:        Join Us
  • 1
  • 2
  • 3
  • 4
  • 5
▪ China’s Market Regulator Reined in Internet Commercial Ads
▪ Stricter than the GDPR, China’s Privacy Law Provides Prohibitive and Control Oblig
▪ China kicked off the 1st national security review on DiDi
▪ Non-prosecution for compliance under ISO 37301 - Dentons lawyers take the world’s
▪ China’s Data Security Law is anything but frightening
▪ Alibaba fined USD 2.68 billion for abusing dominant market position in China
▪ China’s new “Blocking Statute” and the concerns it raised
▪ Survey result: how is bribery risk managed in China?
▪ China’s Administrative Punishment Law Awards Meaningful Credits for Compliance Eff
▪ Salon | How Would the Sanction on Pompeo and Blocking Measures Impact Foreign Comp
▪ Fees to speakers: academic exchange or commercial bribery
▪ China’s Personal Information Protection Law (2)
▪ China’s Personal Information Protection Law (1)
▪ Reading Into China’s Export Control Law
▪ English Translation of Export Control Law of China
▪ China Issued Its List of Unreliable Entities
▪ Demystify Corporate Social Credit System in China
▪ China is deploying “Operation Skynet” to further “Fox Hunt”
▪ China is to award whistleblowers heavily – foreign companies are more vulnerable t
▪ 130 Chinese headhunters arrested, involving breach of 200 million personal info
▪ Corporate Compliance Programs Evaluation Issued by US DOJ (Chinese Translation)
▪ The prospect is promising to commercialize Level-3 autonomous driving in China
▪ Intelligent and digital infrastructures are scheduled to accompany automatic vehic
▪ Will China illegalize VIEs?
▪ You cannot miss the gold rush under China's new Foreign Investment Law
▪ Classified Protection Under China's Cyber Security Law
▪ China is to fast-track law-making in autonomous driving
▪ What compliance obligations to meet to transfer data from within China?
▪ Chinese government uses digital forensics technology to dig bribery evidence
▪ A Chinese medical device distributor fined CNY 50,000 for bribing with Moutai
▪ How would Chinese E-commerce Law affect you (1)?
▪ Conflict between the culture and the Party’s rules: $70 gift money got a director
▪ "Excessive Pricing" from perspective of Competition Law
▪ Does China prohibit cross-border transfer of scientific data?
▪ Hypermarket Caesar jailed for ten years for giving “reward for go-between”
▪ How is environmental protection tax collected in China?
▪ China Redefined Bribery Anticompetitive in Nature
▪ China is to amend its Constitution
▪ Chinese government vowed to crack down on bribe givers more harshly
▪ China has its own Dodd-Frank; the award for whistleblower could be US$ 80K
▪ Chinese government may LIUZHI a suspect of wrongdoing
▪ Cooking clinical trial data is rampant and now criminally punishable in China
▪ 5th Viadrina Compliance Congress
▪ Does a compliance bird eat nothing?
▪ How Are Drugs Being Sold in China Despite the Anti-Corruption Crusading
▪ Chinese whistle-blower lauded while French boss fled out of China
▪ Life Sentence for Deputy Chief Justice of China
▪ Why Is Chinese Anti-bribery Law a Very Important Compliance Obligation?
▪ The Report on Corporate Compliance Management in China (2016)
▪ Use of "predictive coding" in eDiscovery document review…best friend or job replac
 
Home > Anti-Bribery & Fraud
Find Bribery from Invoice Misconducts
By The Compliance Reviews | 2013/11/18 23:23:51

From August of the last year, the Taxation Bureaus in China have been checking if there are any invoice misconducts with pharmaceutical and medical device companies as well as medical treatment organizations.  It seems that the campaign has not come to an end yet because the examination result as General Administration of Taxation announced is just a phase summary.

 

So far, 12,000 businesses were examined involving 437,100 illegal invoices and RMB 15.036 billion (US$ 2.506 billion) face value.  The underpaid tax as much as RMB 3.692 billion (US$ 615 million) was disgorged.

 

By October of 2013, 6,599 medical treatment organizations were examined, 1,700 of which are the State-owned enterprises.  There were 14.98 million invoices collected as examination samples, 92,100 of which exceeded RMB 10,000 (US$ 1,666) in face value.  There were 33,600 pharmaceutical, medical device businesses and profitable medical treatment organizations examined, 291 of which were prosecuted for violating Chinese law.  There were 186 individual suspects arrested.  From examination, 114 bribing cases were discovered involving bribe amount as much as RMB 60.6858 million (US$ 10.1143 million).  There were 36 governmental officials disciplined and punished for taking bribes.

 

You may follow the link to check the news report in Chinese.

 

Regarding tax inspection campaigns, hereinafter are some key take-aways:

-The industries that are closely watched include real estate, construction and installation, drugs and medical devices, catering and entertainment and for-profit education and training.

-Tax inspection is always related with the inspection on invoices and accounting books.

-Tax bureaus spend great efforts in inspecting the authenticity of invoices (e.g., whether or not there is any business related with invoice) with big face value.

-Disbursement categories of meeting expenses, meal fees and office supplies expenses, commission and various service charge are examined and inspected carefully especially as for the invoices related to drugs and medical devices.

-False invoices discovered during the inspection cannot be used for pretax deduction, taxes deduction and tax refunds (exemption) for export and financial reimbursement and accounting.

-The Public Security Bureaus work closely with tax bureaus to prosecute criminal activities.

 

 

 

Tweet Like Email LinkedIn
There are no comments for this journal entry. To create a new comment, use the form below.
    Enter your information below to add a new comment.
Author:   
Email:    (optional)
URL:    (optional)
Content:  
    
  Comment Moderation Enabled
Your comment will not appear until it has been cleared by a website editor.
The Compliance Reviews COPYRIGHT © 2013-19 All Rights Reserved. Supported by International Risk and Compliance Association and International Risk and Compliance Institute Limited. 沪ICP备10034943号-8
沪ICP备19033746号-4
沪公网安备31010502002477号